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Background: The ultra high risk state for psychosis has not been studied in young offender populations. Prison
populations have higher rates of psychiatric morbidity and substance use disorders. Due to the age profile of
young offenders one would expect to find a high prevalence of individuals with pre-psychotic or ultra-high risk
mental states for psychosis (UHR). Accordingly young offender institutions offer an opportunity for early
interventions which could result in improved long term mental health, social and legal outcomes. In the course of
establishing a mental health in-reach service into Ireland’s only young offender prison, we sought to estimate
unmet mental health needs.
Methods: Every third new committal to a young offenders prison was interviewed using the Comprehensive
Assessment of At-Risk Mental States (CAARMS) to identify the Ultra High Risk (UHR) state and a structured interview
for assessing drug and alcohol misuse according to DSM-IV-TR criteria, the Developmental Understanding of Drug
Misuse and Dependence - Short Form (DUNDRUM-S).
Results: Over a twelve month period 171 young male offenders aged 16 to 20 were assessed. Of these 39 (23%,
95% confidence interval 18% to 30%) met UHR criteria. UHR states peaked at 18 years, were associated with lower
SOFAS scores for social and occupational function and were also associated with multiple substance misuse. The
relationship with lower SOFAS scores persisted even when co-varying for multiple substance misuse.
Conclusions: Although psychotic symptoms are common in community samples of children and adolescents, the
prevalence of the UHR state in young offenders was higher than reported for community samples. The association
with impaired function also suggests that this may be part of a developing disorder. Much more attention should
be paid to the relationship of UHR states to substance misuse and to the health needs of young offenders.
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Young offenders have greater levels of psychiatric mor-
bidity and substance use disorders than their peers in
the general population [1-4]. While at liberty, they ex-
perience multiple social disadvantages which impede
their ability to seek and access appropriate treatment [5].
Young offender institutions often act as staging posts
along pathways leading to mental health care, with
young persons presenting via the criminal justice system* Correspondence: kennedh@tcd.ie
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reproduction in any medium, provided the orrather than via community primary care routes [6]. This
affords prison in-reach mental health teams a unique
opportunity to identify those in need of mental health
services and to provide care to a vulnerable group that
may not otherwise receive it. In addition, early interven-
tion for young offenders could result in better long term
mental health, social and legal outcomes.
A recent large systematic review of adult prisoners
from many different countries revealed a pooled preva-
lence of psychosis four times that of the general popula-
tion [7]. In Ireland the six month prevalence of
psychosis in adult prisons was found to be 7.6% for male
remanded prisoners [8] and 2.6% for male sentencedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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populations have reported rates of psychotic disorders
lower than in adults, though ranging from 1 to 10% [1-
4]. Our study is the first to report on the rates of psych-
osis and the Ultra High Risk mental state for psychosis
(UHR) in a young offender prison. We chose to study
the prevalence of UHR mental states rather than other
disorders of high prevalence in prison populations such
as attention deficit hyperactivity disorder (ADHD) which
has received considerable attention in recent years [10].
Our rationale for focusing on UHR was based on the
pragmatic aim of allocating a limited mental health re-
source toward identifying and treating the most serious
mental disorders with the highest healthcare burden.
Reducing the duration of untreated psychosis improves
the prognosis of schizophrenia in terms of symptoms,
functioning and quality of life [11,12]. It is now possible
to identify individuals at imminent risk of developing
psychosis [13-15]. Interventions may then be used to
prevent or delay the onset of psychotic disorders
[16-18], although this remains an area for further re-
search [19,20]. The Comprehensive Assessment of At-
Risk Mental States (CAARMS) is a semi-structured
interview which has been developed to identify indivi-
duals at ‘ultra-high risk’ of developing psychosis [21,22].
The UHR criteria combine the risk factor of age (adoles-
cence to early adulthood) with clinical, state and trait
factors identified as precursors to psychotic illness [22].
Younger age is included in the UHR criteria as it corre-
sponds to the highest incidence for psychosis [23,24].
Young offenders are of a similar age demographic and
therefore high rates of UHR mental states might be
expected in young offenders.
While rates of psychosis in adult prisoners are typically
in the range 2% to 4% [7], much lower rates of psychosis
are reported in young offenders, typically 1% [1-4] be-
cause the onset of disorders such as schizophrenia tends
to be at a later age. High rates of UHR states might how-
ever be expected in young offenders as the precursors to
the high rates of psychosis in adult prisoners. The
CAARMS has been validated in a help-seeking commu-
nity based cohort [21], however only one previous study
has used it in an adult prison setting [25]. To our know-
ledge we are the first group to use the CAARMS to
identify the prevalence of UHR of psychosis among
young offenders.
Objectives
As part of an audit and service development project to
establish a mental health in-reach service for a young
offender institution, we set out to identify the prevalence
of UHR states for developing psychosis and psychotic
disorder in young offenders. Given the age profile (16 to
20 years) of this young offender population wehypothesised that we would find high rates of UHR
states. We expected to identify a higher prevalence of
psychotic disorder as compared to that of the general
population, but due to their younger age we believed this
would be lower than that of adult prison populations. In
addition we aimed to identify the prevalence of general
psychopathology and substance use disorders, hypothe-
sising that we would find high rates of each among
young offenders.Methods
Study design
We interviewed every third person committed to a
young offender institution over a twelve month period.
Those interviewed were seen within seven days of recep-
tion. We used a semi-structured interview for back-
ground and demographic details, a semi-structured
interview for substance misuse [26,27], and the
CAARMS structured interview for ultra-high risk states
of psychosis [21,22]. The study was approved as a clin-
ical and service audit project by the audit, effectiveness
and research ethics committee for the National Forensic
Mental Health Service. All participants gave informed
consent for participation.Setting
St Patrick's Institution is a young offender institution in
Ireland with a bed capacity of 217. At the time of this
study it was the only prison accepting males aged 16 to
20 in the state (population 4.6 m). All committals were
screened by a prison nurse within 6 hours of reception
at the prison and all were seen by a general practitioner
within 24 hours who carried out an unstructured general
health assessment as for any new patient presenting to
primary care. One in three from a list of chronological
receptions was selected for a more detailed assessment
by the visiting psychiatrists (DF and DS, post-
membership psychiatric registrars, equivalent to US fel-
lows or UK ST4). If the person selected was not eligible
because it was their second or subsequent committal,
the next on the list was selected.Participants
Of the 836 committals in the study period, 78 were not
eligible because they were second or subsequent com-
mittals leaving 758 eligible new committals. Every third
committal eligible (n = 278) was selected for interview
and 480 were not selected. Of the 278 selected, 107 were
either released before they could be interviewed,
declined the interview, were absent from the prison at
court, released from custody or transferred to another
prison and the remaining 171 were interviewed.
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The Comprehensive Assessment of At-Risk Mental
States (CAARMS) is a semi structured research diagnos-
tic interview schedule which was developed to reliably
detect the prodrome of first episode psychosis prospect-
ively [21,22]. It has seven subscales (positive symptoms,
cognitive change, emotional disturbance, negative symp-
toms, behavioural change, motor/physical change, and
general psychopathology), each of which are scored from
0 (absent) to 6 (psychotic and severe / extreme). Each
subscale scores for threshold, frequency and duration of
symptoms. It takes account of the relationship between
symptoms and substance use and also measures subject-
ive level of distress caused by symptoms (0–100 scale).
To meet the symptom component of the criteria for
an UHR state, only symptoms in the positive symptom
subscale require assessment. This subscale is comprised
of four domains: Unusual Thought Content (e.g. delu-
sional mood and perplexity, ideas of reference, bizarre
ideas), Non-Bizarre Ideas (e.g. suspiciousness, grandiose
ideas, somatic ideas, nihilistic ideas, religious ideas), Per-
ceptual Abnormalities (e.g. distortions, illusions, halluci-
nations), and Disorganised Speech.
The CAARMS defines three groups which outline cri-
teria required to be diagnosed with the ultra-high risk
state - 1) A “vulnerability” state in which there is a fam-
ily history of psychosis in first degree relative or schizo-
typal personality disorder in the identified patient is
present 2) “attenuated psychosis” , a pattern of psychotic
symptoms which are sub-threshold in intensity or fre-
quency for a diagnosis of psychotic disorder 3) Brief lim-
ited intermittent psychotic symptoms (BLIPS) describes
a recent history of frank psychotic symptoms that
resolved spontaneously without anti-psychotic medica-
tion within one week 4) a fourth category of psychotic
disorder is also included in the CAARMS. This is
defined as symptoms rated above threshold as described
in the CAARMS and present for at least one week.
To fulfil the criteria for each of the UHR groups,
quantitative evidence of functional impairment is also
required as measured by a 30% drop in score on the So-
cial and Occupational Functioning Scale (SOFAS) [28].
The SOFAS is a tethered rating scale ranging from 0
'grossly impaired' to 100 'superior functioning' and dif-
fers from the Global Assessment of Function scale
(GAF) [29] in that it does not include ratings for severity
of symptoms.
Inter-rater reliability was tested by jointly interviewing
and independently scoring 13 individuals, Spearman
rank correlation coefficient r = 0.962, p < 0.001.
Alcohol and substance use disorders were diagnosed
using the short form of the Developmental Understand-
ing of Drug Misuse and Dependence (DUNDRUM-DS)
[26,27]. This instrument was developed by the authorsto elicit DSM-IV diagnostic criteria for substance use
disorders using a brief yet comprehensive interview. We
chose not to use the alcohol and substance use modules
of the Structured Clinical Interview for DSM-IV [30] for
a number of reasons including the longer duration of
interview required and its omission of newer substances
like Mephedrone. The DUNDRUM-DS assesses the se-
verity of use for a range of intoxicants on four levels:
never used, ever used, abuse and dependence. Its validity
is currently being tested in a forensic inpatient popula-
tion. Joint interviewing (DS & DF) and separate scoring
of ten individuals revealed good to excellent inter-rater
reliability (cannabis Cohen's Kappa = 0.855 p < 0.001,
mephedrone k = 0.863 p < 0.001, alcohol, ecstasy, am-
phetamine, cocaine, benzodiazepines and heroin all
k = 1, p < 0.001).Data sources & measurements
All committals were identified by LQ and prison staff
from a computerised list in order of time of reception at
the prison and every third committal was identified. Re-
committals were not eligible and were substituted by the
next on the list. All participants were interviewed by one
of the two psychiatrists (DF & DS).Study size
There is no previous research concerning the preva-
lence of ultra-high risk states in prisons. It is known that
3% of committals to adult prisons in Ireland have a
current psychosis [31], and community help-seeking
samples have shown that between 20% and 40% of ultra-
high risk cases identified in community help seeking
samples go on to develop psychosis [13-15,19,21,23,32,33]
We inferred that with a 20% conversion rate, 15% of com-
mittals to a young offenders group might be expected to
fulfil the ultra-high risk criteria. Using the Confidence
Interval Analysis statistics programme [34], we calculated
that a sample of 100 would detect a 15% prevalence with
a 95% confidence interval of 9.3% to 23.3%.Measures
Cases were grouped according to whether they met cri-
teria for each of the ultra-high risk categories or overall.
Cases were also grouped according to age in one-year
divisions and according to the number of substance mis-
use problems identified (alcohol, ecstasy, amphetamine,
cocaine, mephedrone, heroin, benzodiazepines). Dwell-
ing could only be elicited for the most recent place prior
to committal, and was dichotomised into urban (any
town or city) and rural. Ethnicity was similarly simplified
to Caucasian Irish born, Irish Traveller [35] and other.
836 committals from 
1st June 2011 to 31st
May 2012




278 selected for interview
107 not interviewed
declined - 41







39(23%) meet UHR 
criteria
Figure 1 Recruitment and eligibility.
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All data were stored anonymously and entered in SPSS-
18 [36]. Where needed, added statistics were calculated
using Confidence Interval Analysis [34] to derive relative
risks and their confidence intervals. Age (mean 18.2, SD
1.3, range 16 to 20), SOFAS score (mean 50.4, SD 12.9,
range 20 to 86) and number of substance misuse pro-
blems (mean 2.3, SD 1.8, range 0 to 7) all had the char-
acteristics of normally distributed variables, with no
outlier observations, and mean, median and mode close
in each case. However number of substance misuse pro-
blems was treated as an ordinal.
Chi-squared (χ²) and relative risk statistics were calcu-
lated for associations between ordinal or categorical vari-
ables. Analysis of variance was used for normally
distributed variables and categorical variables such as
UHR state. Binary logistic regression using likelihood
ratio was also used to examine the relationship between
UHR state and co-variates.
Results
Participants
The study commenced on 1st June 2011 and the sample
was completed on 31st May 2012. During this 52 week
period (Figure 1) there were 836 committals of whom
758 were eligible (78 were second or subsequent com-
mittals), 278 were selected in accordance with the proto-
col for interviewing every third reception and 171 were
interviewed. The remaining 107 included 41 who
declined, 36 who were in court when called, 22 who had
already been released, 5 who had already been trans-
ferred to another prison and three others.
Bias
There was no difference in mean age between the 171
selected and interviewed (18.2 years SD 1.3), the 78
selected but not interviewed (18.4 years, SD 1.2) and the
remaining 480 new committals not selected (18.4 years,
SD 1.4) did not differ significantly in age (ANOVA
F= 1.9, df = 2, p = 0.154). There was no significant differ-
ence in legal status (remand or sentenced χ² = 8.4, df = 2,
p = 0.078) though there was a tendency for more sen-
tenced than remands to be seen. There was no differ-
ence in geographic origin, whether from urban or rural
areas (χ² = 2.0, df = 2, p = 0.364).
Descriptive data
Of the 171 who were interviewed, the mean age was
18.2 years (SD 1.3). There were none aged 15 or less, 23
aged 16 (13.5%), 39 aged 17 (23%), 26 aged 18 (15%), 52
aged 19 (30%) and 31 aged 20 (18%). There were none
older than 20. The mean time from reception to inter-
view was 4.1 days (SD2.3, range 0 to 8). No data were
missing for those included in the study and interviewed.Outcome data
Of the 171 interviewed, 131 (77.2%) did not meet UHR
criteria. Of the 39 (22.8%) who met UHR criteria, 5
(3.5%) met the criteria for vulnerability only, 9 (5%) met
criteria for vulnerability and attenuated psychosis, 19
(11.1%) met criteria for attenuated psychosis only, 1
(0.6%) met criteria for attenuated psychosis and brief
limited intermittent psychosis (BLIPS), 2 (1.2%) met cri-
teria for brief limited intermittent psychosis (BLIPS), 1
met criteria for both vulnerability and psychosis (0.6%)
Table 1 Age and ultra-high risk status
Age (years) 16 17 18 19 20 All
N 22 40 28 50 31 171
CAARMS positive 1(4.5%) 10 (25%) 10 (35.7%) 11 (22%) 7 (22.6%) 39(22.8%)
95% confidence interval 1.1 -21.9% 14.2 – 40.3% 20.7 – 54.3% 12.8 – 35.3% 11.4 – 40% 17.2 – 29.7%
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CAARMS - three in all met criteria for psychosis (1.8%).
UHR state was not evenly distributed according to age
(Table 1), with the highest rate amongst 18 year olds
(35.7%, 95% CI 20.7–54.3% compared to all others
20.2%, 95% CI 14.5–27.6%, relative risk 1.6, 95% CI 0.8–
2.9, χ² =3.2, df = 1, p = 0.075).
UHR state was not related to legal status, occurring in
16 of 69 (23.2%) remand and 23 of 102 (22.5%) sen-
tenced committals.
UHR positive state was associated with a lower mean
SOFAS score 39.4(SD 6.6) v 53.7(SD 12.5) (ANOVA
F= 46.5, df = 1, p < 0.001 giving a mean difference of
14.3, 95% CI 10.1 – 18.4).
UHR positive committals did not differ in age from
UHR negative committals (18.1 (SD 1.4) years v 18.3
(SD 1.1), ANOVA F= 0.8. df = 1. p = 0.364.
Any substance misuse problem was present in 146
(85.4%) of those interviewed. The presence of any sub-
stance misuse problem was more common in urban
dwellers (90% -v- 72% χ² = 8.1, p = 0.004) as was multiple
substance misuse (χ² = 14.9, df = 7, p = 0.036). Multiple
substance misuse problems were common, and number
of substance misuse problems was associated with pro-
gressively lower SOFAS scores (Table 2) ANOVA F= 4.2,





mean SD 95% CI
Lower Upper
0 26 58 16.2 51.5 64.5
1 43 54.3 14.2 50 58.6
2 32 49.4 9.4 46 52.8
3 21 46.6 10.4 41.9 51.3
4 24 47.1 11.3 42.4 51.9
5 15 46.3 8.3 41.6 50.9
6 5 43.8 4.1 38.6 49
7 5 35.4 5.6 28.5 42.3
Total 171 50.4 13 48.5 52.4
ANOVA F= 4.2, df = 7, p < 0.001.Main results and other analyses
There was no significant relationship between UHR
state and the presence or absence of any substance
misuse problem (RR= 2.0, 95% CI 0.7 – 6.2, χ² =1.9,
df = 1, P = 0.163). However there was a significant rela-
tionship between UHR status and number of substance
misuse problems (range 0 to 7, χ² = 32.6, df = 7, p < 0.001;
linear by linear association = 22.9, df = 1, p < 0.001)
Table 3.
UHR state was not related to urban–rural dwelling
(χ² = 0.25, df = 1, p = 0.62) or ethnicity (χ² = 5.0, df = 5,
p = 0.45).
When the effect on SOFAS score of UHR state was
examined using univariate analysis of variance to co-vary
for number of substance misuse problems, positive UHR
state had a significant effect on SOFAS score (mean
SOFAS for UHR negatives = 53.7(SD 12.5), UHR posi-
tives = 39.4 (SD 6.6), F = 28.6, df = 1, p < 0.001) and num-
ber of substance misuse problems also had a significant
effect (F = 10.3, df = 1, p = 0.002).
Binary logisitic regression was used with the presence
of the UHR state as dependent variable while multiple
substance misuse and SOFAS scores were co-variates.
Forward stepwise logistic regression with likelihood
ratios yielded both co-variates as significant components






n (% of row) n (% of row) n
0 23 (89%) 3 (11%) 26
1 36 (84%) 7 (16%) 43
2 29 (91%) 3 (9%) 32
3 18 (86%) 3 (19%) 21
4 17 (71%) 7 (29%) 24
5 6 (40%) 9 (60%) 15
6 2 (40%) 3 (60%) 5
7 1 (20%) 4 (80%) 5
Total 132 39 171
χ² = 32.6, df = 7, p < 0.001.
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score odds ratio 0.864, 95% CI 0.814-0.917, p = 0.001).
This model was robust and emerged also from backward
stepwise logistic regression using likelihood ratios.
Discussion
Key results
We have found that 22.8% (95% CI 17.7% - 30.3%) of
new committals to a young offender institution met cri-
teria for ultra-high risk of psychosis. UHR state peaked
at age 18 and was associated with increasing number of
substance misuse problems. UHR state was strongly
associated with lower SOFAS scores, even when correct-
ing for multiple substance misuse problems.
Limitations
This finding may not translate into the high rates of transi-
tion to psychosis reported in community studies of help-
seeking patients [13-15,19,23,32]. However the strong
relationship here between UHR state and lower SOFAS
scores suggests that the UHR state identified in this study
is associated with meaningful impairments. This is a cross-
sectional study and so cannot distinguish cause from effect.
However the results are in keeping with prior research on
the relationship between schizophrenia and other psych-
oses and risk factors such as multiple substance misuse
[37] while not confirming a direct relationship with urban
residence [38,39]. This study was based in a young offen-
ders institution for males (youths) and may not extrapolate
to young women. The number of women of all ages com-
mitted to prison is very small, of the order of 10% of all
committals and they are received in a separate women's
prison [40].
Interpretation
New receptions in adult prisons are known to have a
high rate of psychiatric morbidity [7,31] and may fall
through the net of community services because of social
exclusion [41] and specific lack of accessibility of com-
munity mental health services for young people [6].
Our finding of very high rates of co-morbidity between
the ultra-high risk (UHR) state and multiple drug and al-
cohol misuse problems should be interpreted with cau-
tion. Adult offenders on reception in prison are known
to have high rates of drug and alcohol problems as a
norm [7,42] and comparable rates were found in young
offenders groups elsewhere [2,4]. Nonetheless we have
shown that multiple drug and alcohol problems carried
a progressively increased risk of the UHR state. Con-
versely, UHR state was associated with significantly
impaired SOFAS scores, even when co-varying for mul-
tiple substance misuse. There is a well-described link be-
tween cannabis use in adolescence and the later
development of schizophrenia [43] though the link maybe less specific for UHR states [44]. Many studies of
psychotic symptoms in help-seeking populations and in
random community samples of young people omit to
survey for co-morbid substance misuse.
The apparent peak age of 18 for the UHR state suggests
that this may be a manifestation of a developmental vul-
nerability period [45,46]. It may be that there is an inter-
action between toxic effects of drugs and alcohol and a
developmental vulnerability such as neural pruning in
late adolescence [45]. The stress of imprisonment may be
an exacerbating factor, as may psychosis itself [46].
Urban–rural residence may have complex effects on
the risk of psychosis [38,39], but in this study urban–
rural residence appeared not to be a significant risk fac-
tor for the UHR state and may require further study
when new census data become available.
Delusions and hallucinations have recently been
described in random community samples of children
and younger adolescents drawn from the same areas of
Ireland as in this study [47]. Auditory hallucinations and
other symptoms were present in between 21% and 23%
of a community sample of 11 to 13 year olds (early ado-
lescents), associated with a diagnosis in 57%, but present
only in 7% of a community sample of 13 to 16 year olds
(mid adolescents), though associated with a diagnosis in
80% [47]. Symptoms, mainly auditory hallucinations,
were more common in boys. The associated diagnoses
were emotional, hyperkinetic and conduct disorders, and
the more disorders diagnosed, the more likely the young
person was to report auditory hallucinations. Auditory
hallucinations may not be predictive of psychosis par-
ticularly in the younger age group, but the 'hardening' of
the association with psychiatric disorders in the mid-
adolescent age group requires further research to deter-
mine the prognosis for later psychosis. The UHR state as
defined by the CAARMS elicits symptoms but also
includes positive family history of psychosis and brief
psychotic episodes as well as sub-threshold symptoms so
the UHR state described here is not directly comparable
with the symptoms elicited in the study by Kelleher
et al. [47]. Our population of 16 to 20 year old Irish male
young offenders cannot be directly compared but our
finding of the UHR state in 23% associated with impair-
ments of function and multiple substance misuse may
represent a further developmental step on the way to the
emergence of a severe and enduring psychosis in some of
that 23%. Help-seeking populations, community samples
with symptoms and diagnosable disorders and high risk
populations such as young offenders all require prospective
follow-up studies to determine the prognostic significance
of the UHR state. For future research, we would hypothe-
sise that there may not be differences in prognosis between
these groups once the full criteria for UHR state [21,22]
are met.
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cause from effect. However there must now be a compel-
ling argument for the provision of drug-free wings in pris-
ons, particularly in young offender institutions. There is a
more general question about the relationship between
UHR states and substance misuse in community samples
of young people. The provision of drug and alcohol aware-
ness education may also account for the declining transi-
tion rates in recent studies of the ultra-high risk status
[19,48].
Conclusions
Young offenders institutions offer a unique opportunity
to identify those who meet criteria for ultra-high risk of
psychosis. While the prognostic significance of the UHR
state in this group is unknown, the association with
impaired functioning in itself should merit a mental
health intervention, and the link with multiple substance
misuse shows a need for psycho-education and motiv-
ational work in a drug-free environment while in prison.
Further research is required concerning the link between
the UHR state, psychosis and substance misuse in this
age group.
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